Clinical proteomics tumor analysis consortium (cptac) biospecimen core resource

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500055C
Awardee
Awarding agency
Obligated
$5,737,798

Award facts

Opportunity
Contract value 100% obligated
  • $5,737,798.31 Current, with exercised options
  • $5,744,178.31 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Wyoming, MI 49503, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 -$307,775
Supplemental Agreement for work within scope P00012 · Provide specimens and related data in support of the clinical proteomics tumor analysis consortium (cptac) program -$37,181
Other Administrative Action P00011 · Purpose: 1) deobligate unexpended FY 2015 funds from prism line item number (plin) 1 of the subject contract and 2) change the contracting officer's… -$185,967
Other Administrative Action P00010 · Purpose: to update the fisma deliverable requirements and revise the affected contract articles c.2, f.2 and h.15. And h.16. $0
Exercise an Option P00009 · Option year 4, optional quantity for clia antibody staining and optional quantity for clia interpretation POP: 09/01/2019 - 08/31/2020. $1,257,219
Other Administrative Action P00008 $0
Exercise an Option 7 $1,226,718
Exercise an Option 6 $1,200,203
Other Administrative Action 5 $0
Exercise an Option 4 $1,215,343
Other Administrative Action 3 $0
Supplemental Agreement for work within scope 2 $0
Other Administrative Action 1 $0
Original award $1,369,238
Show all 14

About this award

Written by GovTribe AI ·

This is a $5,744,178.31 definitive contract awarded by the National Cancer Institute (NCI) to the Van Andel Research Institute (VAI) to serve as the Biospecimen Core Resource for the Clinical Proteomics Tumor Analysis Consortium (CPTAC) program. The contract has a period of performance through August 30, 2021. VAI is an independent non-profit biomedical research organization that specializes in areas such as cancer, neurodegenerative diseases, and structural biology. Through this contract, VAI will provide biospecimen acquisition, storage, and research services to support the NCI's Cancer Moonshot Biobank initiative. This contract does not have a set-aside designation. VAI currently holds a larger $48.6 million indefinite delivery contract with the NCI to continue providing biobanking services through June 2027 for the Cancer Moonshot Biobank program.

Quick answers

Who was awarded contract HHSN261201500055C?

HHSN261201500055C was awarded to Van Andel Research Institute by National Cancer Institute (National Institutes of Health) on September 29, 2015.

How much is contract HHSN261201500055C worth?

The government has obligated $5,737,798 on HHSN261201500055C. Its potential value, with all options, is $5,744,178.

Was contract HHSN261201500055C competed?

The extent of competition for HHSN261201500055C was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login